Thus, in addition to taking into account the level at which the SHH pathway is compromised when designing targeted therapy, intrinsic characteristics of the cell-of-origin preserved in the tumor should also be taken into consideration (Hassounah et al., 2012; Zhao et al., 2017). Here, SHH is linked to neoplasm.